ArticleWomen's health reports (New Rochelle, N.Y.)2024
Risk Perception for Developing Cardiometabolic Disease Among Women Diagnosed with Preeclampsia and Gestational Diabetes Mellitus.
Article in Women's health reports (New Rochelle, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Adverse pregnancy outcomes, longitudinal change in eGFR, and incident hypertension in women: a population-based cohort study.Renal failure · 2026Article
- Type 2 Diabetes Risk Perception and Health Behaviors Among Women with History of Gestational Diabetes Mellitus: A Retrospective Analysis.Nutrients · 2025Article
- Hypertensive disorders of pregnancy and gestational diabetes mellitus and predicted risk of maternal cardiovascular disease 10-14 years after delivery: A prospective cohort.Diabetic medicine : a journal of the British Diabetic Association · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Adverse pregnancy outcomes (APO), including preeclampsia (PE) and gestational diabetes mellitus (GDM), increase the future risk of developing cardiometabolic disease (CMD), such as cardiovascular disease and type 2 diabetes mellitus (T2DM). CVD is the leading cause of death among women. Despite the well-established relationship between APO and CMD, women's awareness is limited. We aimed to assess and compare risk perception for future CMD among women with PE and GDM. Methods: Women diagnosed with PE and GDM between 2015 and 2020 at the University Hospital St. Pölten were identified. Telephone interviews were conducted to assess women's risk perception of future CMD. Results: Of the 161 women included in the study, approximately half had a high risk perception of future CMD. Women with PE ( Conclusion: This study demonstrated a lack of risk perception for future CMD among women with APO, underscoring the need for improved patient education during and after pregnancy. To increase risk perception, it is crucial to educate women about the long-term risks associated with APO, emphasize the severity of CMD, and promote lifestyle interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.